NPI registry status
Active
2026 NPPES data Urology Physician NPI 1720085699 MD
Verify on CMS → Clyde Roy, MD
Urology Physician in New Iberia, Louisiana.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 13,606 in Urology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
233
Medicare Part D claims · 102 beneficiaries · Urology Physician avg: 1K
Generic prescribing
84%
generic claims · 16% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
68.3/100
▼ 15 pts below national avg 83.5 · Mid-tier
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Clyde Roy, MD reported a CMS MIPS final score of 68.3/100 - below the 83.5 national average - and filed 233 Medicare Part D claims in 2024.
- 68.3/100
- MIPS score · -15 vs avg
- 233
- Part D claims, 2024
- 84%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Clyde Roy, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1720085699), first enumerated 07/06/2005.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 233 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 68.3/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1720085699 · Urology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-LOW · RX-LIGHT · BOOK-THIN · PHOTO-FINISH
- NPI-10 1720085699
- ENUM-LEGACY 2005
- TAX-MID 14K Urology Physician
- MIPS-LOW 68.3/100
- RX-LIGHT 233
- BOOK-THIN 194 in Louisiana
- PHOTO-FINISH James Bresee · ±0.2
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Roy · this provi…
Roy · this provider
68.3 MIPS pts
- Sara Spettel · h…
Sara Spettel
68.5 MIPS pts
- James Bresee · n…
James Bresee
68.5 MIPS pts
- Gregory Cost · n…
Gregory Cost
68.5 MIPS pts
- Theresa Koppie ·…
Theresa Koppie
68.5 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Clyde Roy, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
68 ≥ 8th percentile 8% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Clyde Roy, MD sits
This provider among urology physician peers
Across the 4,091 urology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Clyde Roy, MD writes more Part D claims than 14% of them and scores higher on MIPS quality than 8% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one urology physician peer from a representative sample of 60; the gold marker is Clyde Roy, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Clyde Roy, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Clyde Roy, MD?
Below national averagePrimary specialty
Urology Physician
Medicare Part D claims
233 83% vs specialty avg
MIPS final score
68.3/100 15.2 pts vs avg
Specialty distribution in Louisiana
How Urology Physician compares to other specialties among Louisiana providers
Medicare quality performance, MIPS
Clyde Roy, MD's 2023 MIPS final score plotted against the Urology Physician national average
- MIPS Final Score
- 68.3/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1720085699 |
|---|---|
| Specialty | Urology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 07/06/2005 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
68.2922
Final Score
Measured-score avg: 83.5
58.7808
Quality
50.9557
Cost
70
Promoting Interoperability
Reporting: Group practice
Brand vs generic prescribing mix · Typical
Clyde Roy, MD - brand share 16.0%
Urology Physician average
16% brand-name claims vs 84% generic, on 233 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
233
Total Claims
$39K
Total Drug Cost
102
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 449.767
- Total Day Supply
- 13,379
- Brand vs Generic
- 16% brand / 84% generic
- Brand Drug Cost
- $36K
- Generic Drug Cost
- $3K
Patient Demographics
- Average Patient Age
- 75.3 years
- Avg HCC Risk Score
- 1.42
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Clyde Roy, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Tamsulosin Hcl
Tamsulosin Hcl
76 claims
- Finasteride
Finasteride
47 claims
- Dutasteride 23
Dutasteride
23 claims
- Myrbetriq 22
Myrbetriq
22 claims
- Gemtesa 12
Gemtesa
12 claims
| Drug | Claims |
|---|---|
| Tamsulosin Hcl | 76 |
| Finasteride | 47 |
| Dutasteride | 23 |
| Myrbetriq Mirabegron | 22 |
| Gemtesa Vibegron | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Urology Physician Overview
How Clyde Roy, MD fits within the Urology Physician landscape nationally.
13,606
Urology Physician Providers in US
54
States with Urology Physician
1,354
Avg Claims per Provider
Clyde Roy, MD's 233 claims are below the specialty average of 1,354.
Nationwide Urology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Roy, both outside Louisiana so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (68.3 here).
Same NPPES enumeration year (2005)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Urology Physician Providers in Louisiana
Other clinicians with the same primary specialty enrolled in Louisiana, drawn from the same CMS NPPES roster as Roy.
One of 194 Urology Physician providers enrolled in Louisiana, 5 are shown here.
Dr. Thomas Alderson
M.D.
Sulphur, LA
Dr. Wael Almajed
MD
New Orleans, LA
Dr. Rajendran Ambiavagar
MD
Alexandria, LA
Jacob Anderson
New Orleans, LA
Dr. Angelo Annaloro
M.D.
Baton Rouge, LA
Compare Urology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Clyde Roy, MD's specialty? ▼
Clyde Roy, MD specializes in Urology Physician and practices in New Iberia, Louisiana. Credentials: MD.
How much does Clyde Roy, MD prescribe under Medicare Part D? ▼
In 2024, Clyde Roy, MD wrote 233 Medicare Part D claims totaling $39K in drug costs for 102 beneficiaries.
What is Clyde Roy, MD's Medicare quality score? ▼
Clyde Roy, MD has a CMS MIPS Final Score of 68.3/100 (Quality: 58.8, Cost: 51). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Clyde Roy, MD located? ▼
Clyde Roy, MD is located at 602 N LEWIS ST, New Iberia, LA, 70563. Phone: (337) 365-4113.
What is Clyde Roy, MD's NPI number? ▼
Clyde Roy, MD's National Provider Identifier (NPI) is 1720085699, issued on 07/06/2005.
Does Clyde Roy, MD prescribe more brand-name or generic drugs? ▼
Clyde Roy, MD's prescribing is 16% brand-name and 84% generic drugs by claim count, with $36K in brand drug costs.
How many Urology Physician providers are there in the US? ▼
There are 13,606 Urology Physician providers across 54 states in the US. The average Urology Physician provider writes 1,354 Medicare Part D claims per year.
What drugs does Clyde Roy, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Clyde Roy, MD's most frequently prescribed drugs include Tamsulosin Hcl, Finasteride, Dutasteride. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Clyde Roy, MD accept Medicare? ▼
Clyde Roy, MD appears in CMS Medicare data with 233 Part D claims and 102 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Clyde Roy, MD's credentials? ▼
Clyde Roy, MD's NPI is 1720085699 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.